Skip to main content

Hls Therapeutics Inc(HLS-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Hls Therapeutics Inc down on Tuesday (HLS)

Automated Summaries - The Globe and Mail - Tue Apr 9, 4:02PM CDT

Today in trading, Hls Therapeutics Inc shares closed at $4.99 after opening the day at $5.34. Intraday prices ranged from a low of $4.97 to a high of $5.34.

The price dipped -0.99 percent from the previous day's close of $5.04.

Today across North America, the TSX Composite closed -0.02% at 22260.30, the S&P 500 closed -0.04% at 5202.39, the Dow Jones Industrial Average closed -0.03% at 38892.80 and the Nasdaq Composite closed 0.03% at 16253.96.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 16,630 shares was traded during the session, with total trades of 62. On average, Hls Therapeutics Inc has traded 11,795 shares over the last 5-days and 10,093 year-to-date.

The TSX overall saw 2,909 price advancers against 2,322 declines and 125 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, the shares have dipped -19.65 percent in the last 12 months, while they have advanced 26.33% since the start of 2024.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $160.88 million on a float of 31,921 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc's average recommendation is "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe